<unk> (injection) is a beta-adrenergic blocker, cardioselective that is FDA approved for the treatment of hemodynamically stable patients with definite or suspected acute myocardial infarction to reduce cardiovascular mortality.   Common adverse reactions include bradyarrhythmia , heart block , heart failure, hypotension , pruritus , rash, constipation , diarrhea , indigestion, nausea
dizziness, fatigue , headache, depression, dyspnea , wheezing.
Metoprolol tartrate 
Metoprolol succinate 
Bisoprolol
Hydralazine 
Endralazine
Captopril
Digitoxin
Digoxin